COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,400 Articles (22,816 medRxiv, 8,584 bioRxiv)

Most recent first Previous |  Page 1039: Articles 10381-10390  | Next

Viral cultures, PCR Cycle threshold values and viral load estimation for COVID-19 infectious potential assessment in transplant patients: systematic review - Protocol Version 29 December 2021
Jefferson, T., Spencer, E. A., Maltoni, S., Brassey, J., ONAKPOYA, I., Rosca, E. C., Pludderman, A., Evans, D., Conly, J., Heneghan, C.
10.1101/2021.12.30.21268509 — Posted: 2022-01-01
Point-of-care lung ultrasound predicts severe disease and death due to COVID-19: a prospective cohort study.
Blair, P. W., Siddharthan, T., Liu, G., Bai, J., East, J., Herrera, P., Anova, L., Mahadevan, V., Hossen, S., Seo, S., Sonuga, O., Lawrence, J., Peters, J., Cox, A., Manabe, Y. C., Fenstermacher, K., Shea, S., Rothman, R. E., Hansoti, B., Sauer, L., Crainiceanu, C., Clark, D. V.
10.1101/2021.12.30.21268558 — Posted: 2022-01-01
COVIDFast: A high-throughput and RNA extraction-free method for SARS-CoV-2 detection in swab (SwabFAST) or saliva (SalivaFAST)
Qiu, Y., Lu, L., Halven, A., Terrio, R., Yuldelson, S., Dougal, N., Galbo, F., Lu, A., Gao, D., Blomquist, B., Zevallos, J., Harry, B., Yao, X., Lu, S.-L.
10.1101/2021.12.29.21268527 — Posted: 2022-01-01
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancies and COVID-19: a longitudinal cohort and propensity score analysis
Hueso, t., Godron, A.-S., Lanoy, E., Pakanowski, J., Levi, L. I., Gras, E., Surgers, L., Guemriche, A., Meynard, J.-M., Pirenne, F., Idri, S., Tiberghien, P., Morel, P., Besson, C., Dulery, R., Lamure, S., Hermine, O., Gagneux-Brunon, A., Freymond, N., Grabar, S., Lacombe, K.
10.1101/2021.12.29.21268525 — Posted: 2022-01-01
Estimating the direct Disability-Adjusted Life Years (DALYs) associated with SARS-CoV-2 (COVID-19) in the Republic of Ireland: The first full year
Moran, D. P., Montero Pires, S., Wyper, G. M., Devleesschauwer, B., Cuschieri, S., Kabir, Z.
10.1101/2021.12.29.21268120 — Posted: 2022-01-01
Transition of antibody titers after the SARS-CoV-2 mRNA vaccine in Japanese healthcare workers
Kitabatake, M., Ouji-Sageshima, N., Sonobe, S., Furukawa, R., Konda, M., Hara, A., Aoki, H., Suzuki, Y., Imakita, N., Nakano, A., Fujita, Y., Shichino, S., Nakano, R., Ueha, S., Kasahara, K., Muro, S., Yano, H., Matsushima, K., Ito, T.
10.1101/2021.12.28.21268435 — Posted: 2021-12-31
Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
Mazzoni, A., Vanni, A., Spinicci, M., Lamacchia, G., Kiros, S. T., Rocca, A., Capone, M., Di Lauria, N., Salvati, L., Carnasciali, A., Mantengoli, E., Farahvachi, P., Zammarchi, L., Lagi, F., Colao, M. G., Liotta, F., Cosmi, L., Maggi, L., Bartoloni, A., Rossolini, G. M., Annunziato, F.
10.1101/2021.12.29.21268469 — Posted: 2021-12-31
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
Roessler, J., Pich, D., Albanese, M., Wratil, P. R., Kraehling, V., Hellmuth, J. C., Scherer, C., Bergwelt-Baildon, M. v., Becker, S., Keppler, O. T., Brisson, A., Zeidler, R., Hammerschmidt, W.
10.1101/2021.12.29.21268487 — Posted: 2021-12-31
Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: a single-blind randomized controlled trial
Arnardottir, H., Pawelzik, S.-C., Sarajlic, P., Quaranta, A., Kolmert, J., Religa, D., Wheelock, C. E., Back, M.
10.1101/2021.12.27.21268264 — Posted: 2021-12-31
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Di Fusco, M., Lin, J., Vaghela, S., Lingohr-Smith, M., Nguyen, J. L., Scassellati Sforzolini, T., Judy, J., Cane, A., Moran, M. M.
10.1101/2021.12.29.21268511 — Posted: 2021-12-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).